About this trial
Knee osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage wear, leading to pain, stiffness, and joint swelling. It is highly prevalent in aging populations and is strongly associated with obesity and previous joint injury. OA affects millions of individuals worldwide, with incidence and prevalence increasing markedly with age and resulting in significant functional disability
The primary therapeutic goals in the management of knee osteoarthritis are pain reduction and improvement of joint mobility.
Total knee arthroplasty is considered one of the most effective surgical interventions for relieving pain and restoring function in patients with severe knee osteoarthritis. Nevertheless, residual pain and limited functional improvement remain the most frequent causes of patient dissatisfaction following TKA
Genicular nerve radiofrequency ablation (GNRFA) has emerged as an innovative treatment option for symptomatic knee osteoarthritis. This technique has been shown to reduce pain and improve function, with clinical benefits often observed as early as one week after treatment. GNRFA consistently provides short-term pain relief (3 to 6 months) and, in some cases, longer-lasting benefits.
The hypothesis tested in this study is whether GNRFA performed at least two weeks preoperatively can reduce postoperative pain and improve postoperative function.
Eligibility criteria
Qualifiers
Age between 18 and 60
Elective total knee arthroplasty
2 to 6 weeks before the procedure
BMI > 35
Disqualifiers
Previous prosthetic surgery on the same knee (i.e. redo surgery, open reduction internal fixation, knee hemiarthroplasty)
Major psychiatric disorder (i.e. major depression, schizophrenia)
Patient refusal
Inability to communicate with the patient and obtain informed consent
Trial design
Treatments tested in this trial
- Radiofrequency ablation of the genicular nerve, 42 degrees Celsius for 120 seconds